John E. Edwards

Fondatore presso NovaDigm Therapeutics, Inc.

Consumer Services

Commercial Services

Health Technology

Profilo

John E.
Edwards is the founder of NovaDigm Therapeutics, Inc. which was founded in 2005.
Currently, he is a Professor at the University of California, Los Angeles.
Previously, he worked as a Member at NIH Research, Inc. Dr. Edwards completed his undergraduate degree at Pomona College and his doctorate at the University of California, Berkeley.

Posizioni attive di John E. Edwards

Società	Posizione	Inizio
University of California, Los Angeles	Corporate Officer/Principal	-
NovaDigm Therapeutics, Inc. NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND.	Fondatore	01/01/2005

Tutte le posizioni attive di John E. Edwards

Precedenti posizioni note di John E. Edwards

Società	Posizione	Fine
NIH Research, Inc. NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di John E. Edwards

Formazione di John E. Edwards

Pomona College	Undergraduate Degree
University of California, Berkeley	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John E. Edwards

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
NIH Research, Inc. NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL.	Commercial Services
NovaDigm Therapeutics, Inc. NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND.	Health Technology